Skip to main content

Chembl_09 Schema - A Different View


The guys at the NCI Cactus blog have done a great job of rendering the new ChEMBL schema as released in ChEMBL_09. There are quite a few changes, and we have started to load/curate new data against this schema - so check with us if your analyses rely on something currently in there! Click on the above image for a large view.

Things will be fairly quiet at ChEMBL Manor next week - we have the annual ChEMBL training course which will keep us busy, and hopefully out of any trouble.

Comments

Thanx again for for tweet earlier about aminoglutethimide. Now, looking at the new scheme, and the ChEMBL content, I see it does it equally wrong as most other databases: the entry is marked as a single chemical graph (without stereo) rather than it being a racemic mixture. If it did, I would not have needed your tweet for the explanation :)

Now, ChEBI actually has a good mechanism for making the distinction (talk to Janna). What are the plans with ChEMBL in this respect? Will we see this corrected? It clearly affects QSAR modeling, as the assay activities are actually related to either one of the stereoisomers in the racemic mixture, or a mix of both. That said, QSAR descriptors will have to take either geometry to calculate 3D descriptors, and as such introduces needless uncertainty in the model.

(And, obviously, this also affects how I should represent things in RDF :)
jpo said…
We have some plans in progress for this. Things are never simple. since we need to catch things like d and l (so unknown but opposite) and trans across two adjacent stereocenters, etc. Just because a chemist publishes something without stereochem shown, doesn't necessarily mean it is racemic.

Our initial focus will be on annotating the issues, to aid interpretation and curation.

A further complication we have come to in the past is for some of the 'neglected' stereocenters, like sulphones. Finally, an interesting clinical candidate case we have corresponded with ChemSpider recently over is flesinoxan - where there are ambiguous links between the +/- and R/S.

I think an interesting area of chemoinformatics science at the moment, with quite a lot more potential is in the area of reduced representation (in contrast to ever more explicit enumeration and calculation). The potential to develop robust landscapes at a lower 'resolution' is quite exciting.

For calculating 3D descriptors, with undefined stereochemistry in lots of cases, or large numbers of possible enantiomers, coupled with large numbers of tautomers, and the problem of pKa prediction and assignment. I wish you the very best of luck.
Unknown said…
Is there more cross-linked information for the schema with respect to entries?
Example:
* What does assays.assay_type={A,B,F,U} stand for?
* Is is possible to expose a few example SQL queries somewhere?

Popular posts from this blog

A python client for accessing ChEMBL web services

Motivation The CheMBL Web Services provide simple reliable programmatic access to the data stored in ChEMBL database. RESTful API approaches are quite easy to master in most languages but still require writing a few lines of code. Additionally, it can be a challenging task to write a nontrivial application using REST without any examples. These factors were the motivation for us to write a small client library for accessing web services from Python. Why Python? We choose this language because Python has become extremely popular (and still growing in use) in scientific applications; there are several Open Source chemical toolkits available in this language, and so the wealth of ChEMBL resources and functionality of those toolkits can be easily combined. Moreover, Python is a very web-friendly language and we wanted to show how easy complex resource acquisition can be expressed in Python. Reinventing the wheel? There are already some libraries providing access to ChEMBL d

ChEMBL 29 Released

  We are pleased to announce the release of ChEMBL 29. This version of the database, prepared on 01/07/2021 contains: 2,703,543 compound records 2,105,464 compounds (of which 2,084,724 have mol files) 18,635,916 activities 1,383,553 assays 14,554 targets 81,544 documents Data can be downloaded from the ChEMBL FTP site:   https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_29 .  Please see ChEMBL_29 release notes for full details of all changes in this release: https://ftp.ebi.ac.uk/pub/databases/chembl/ChEMBLdb/releases/chembl_29/chembl_29_release_notes.txt New Deposited Datasets EUbOPEN Chemogenomic Library (src_id = 55, ChEMBL Document IDs CHEMBL4649982-CHEMBL4649998): The EUbOPEN consortium is an Innovative Medicines Initiative (IMI) funded project to enable and unlock biology in the open. The aims of the project are to assemble an open access chemogenomic library comprising about 5,000 well annotated compounds covering roughly 1,000 different proteins, to synthesiz

Julia meets RDKit

Julia is a young programming language that is getting some traction in the scientific community. It is a dynamically typed, memory safe and high performance JIT compiled language that was designed to replace languages such as Matlab, R and Python. We've been keeping an an eye on it for a while but we were missing something... yes, RDKit! Fortunately, Greg very recently added the MinimalLib CFFI interface to the RDKit repertoire. This is nothing else than a C API that makes it very easy to call RDKit from almost any programming language. More information about the MinimalLib is available directly from the source . The existence of this MinimalLib CFFI interface meant that we no longer had an excuse to not give it a go! First, we added a BinaryBuilder recipe for building RDKit's MinimalLib into Julia's Yggdrasil repository (thanks Mosè for reviewing!). The recipe builds and automatically uploads the library to Julia's general package registry. The build currently targe

Identifying relevant compounds in patents

  As you may know, patents can be inherently noisy documents which can make it challenging to extract drug discovery information from them, such as the key targets or compounds being claimed. There are many reasons for this, ranging from deliberate obfuscation through to the long and detailed nature of the documents. For example, a typical small molecule patent may contain extensive background information relating to the target biology and disease area, chemical synthesis information, biological assay protocols and pharmacological measurements (which may refer to endogenous substances, existing therapies, reaction intermediates, reagents and reference compounds), in addition to description of the claimed compounds themselves.  The SureChEMBL system extracts this chemical information from patent documents through recognition of chemical names, conversion of images and extraction of attached files, and allows patents to be searched for chemical structures of interest. However, the curren

New Drug Warnings Browser

As mentioned in the announcement post of  ChEMBL 29 , a new Drug Warnings Browser has been created. This is an updated version of the entity browsers in ChEMBL ( Compounds , Targets , Activities , etc). It contains new features that will be tried out with the Drug Warnings and will be applied to the other entities gradually. The new features of the Drug Warnings Browser are described below. More visible buttons to link to other entities This functionality is already available in the old entity browsers, but the button to use it is not easily recognised. In the new version, the buttons are more visible. By using those buttons, users can see the related activities, compounds, drugs, mechanisms of action and drug indications to the drug warnings selected. The page will take users to the corresponding entity browser with the items related to the ones selected, or to all the items in the dataset if the user didn’t select any. Additionally, the process of creating the join query is no